Cargando…
Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?
Platelet-derived large extracellular vesicles (often referred to as microparticles in the field of cardiovascular disease) have been identified as effector in the atherothrombotic process, therefore representing a target of pharmacological intervention of potential interest. Despite that, limited ev...
Autores principales: | Taus, Francesco, Meneguzzi, Alessandra, Castelli, Marco, Minuz, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857039/ https://www.ncbi.nlm.nih.gov/pubmed/31780927 http://dx.doi.org/10.3389/fphar.2019.01256 |
Ejemplares similares
-
Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles
por: Giacomazzi, Alice, et al.
Publicado: (2016) -
Exposure to Perfluoroalkyl Chemicals and Cardiovascular Disease: Experimental and Epidemiological Evidence
por: Meneguzzi, Alessandra, et al.
Publicado: (2021) -
Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells
por: Contursi, Annalisa, et al.
Publicado: (2023) -
Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs
por: Minuz, Pietro, et al.
Publicado: (2018) -
Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022)